Taiwan Government Supports Creating Solid Clinical Trial Environment - DIA Exclusive
This article was originally published in PharmAsia News
Executive Summary
BOSTON - Taiwan's Bureau of Pharmaceutical Affairs and Center for Drug Evaluation brought a large delegation to promote the country's clinical trial environment at the Drug Information Association's 44th annual meeting held this year in Boston. BPA Deputy-Director General Li-Ling Liu and CDE Executive Director Herng-Der Chern, spoke with PharmAsia News on the sidelines of the conference about the country's efforts to make Taiwan an attractive location for clinical development
You may also be interested in...
Taiwan To Establish Government-Run VC Fund, Biotech R&D Center
HONG KONG - Looking to shore up a weakness in its ability to transform research into commercially viable products and strengthen its position in the biotech and pharmaceutical sectors, the Taiwan government announced several measures in the past few weeks that will see it create a research and development center and a government-run venture capital fund
Taiwan To Establish Government-Run VC Fund, Biotech R&D Center
HONG KONG - Looking to shore up a weakness in its ability to transform research into commercially viable products and strengthen its position in the biotech and pharmaceutical sectors, the Taiwan government announced several measures in the past few weeks that will see it create a research and development center and a government-run venture capital fund
Lack Of Funding and Political Will Hinders Hong Kong’s Untapped Drug Discovery Research – ChinaBio Investor Forum
HONG KONG - Generally overshadowed by Singapore or Taiwan as a pharmaceutical and biotech center in Southeast Asia, Hong Kong has deep reserves of untapped knowledge and intellectual property